By Emea Riga
MedLife has completed the acquisition of 50% of the shares of Neolife Romania oncology centers, following its approval by the Competition Council. It is the largest transaction initiated by MedLife in 2021
Thus, the MedLife Group consolidates its integrated oncology diagnosis and treatment services through the 4 Neolife medical centers in Bucharest (2), Iași and Brașov that will offer Romanian patients state-of-the-art technology, international medical know-how provided by multidisciplinary teams, experts in the most advanced procedures of diagnosis and oncological treatment. Moreover, the Neolife team has managed to develop excellent services in radiotherapy and nuclear medicine in neighboring countries such as Bulgaria and the Republic of Moldova and, in this context, the MedLife Group will expand partnerships that will go beyond Romania’s borders.
“MedLife’s strategic goal is to strengthen the area of oncology through a holistic approach that ranges from cancer prevention, diagnosis and treatment to ensuring the quality of life of the cancer patient. From now on, we will mark it with the unbeatable experience of Neolife in order to ensure access to hyper-personalized top care “, mentioned Mihai Marcu, CEO of MedLife.
“Together with MedLife, we are becoming a benchmark for our approach and effectiveness in treating cancer. Both by expanding the medical infrastructure and increasing the accessibility of cancer patients to top services, but especially by ensuring the long-term quality of Romanian health. We are not in the most optimistic scenario in the cancer area with 95,000 new cancers and about 54,000 cancer deaths in 2021, with the pandemic leading to significant delays in diagnosis and treatment. But even if the expectation is to increase the number of patients diagnosed with cancer or in advanced stages, there is also a leap in research and innovation through which our state-of-the-art therapies provide effective weapons in the fight against cancer. In Romania we have a very well-established team of professionals, led by Fabio Razzetto, our national manager “, said Ismail Dernek, CEO of MNT Healthcare Group.
Neolife Medical Center Romania, with a total of over 250 employees and collaborators, ended 2021 with a turnover of 110 million lei, increasing by 20% compared to 2020.
MedLife Group will continue its dynamic expansion strategy after acquiring 6 companies last year: CED Pharma (June 2021), Leti Farm (June 2021), Monix Pharm (June 2021), Pharmachem Distribution (July 2021), which were consolidated . They were joined in November last year by Neolife Medical Center. Also at the end of last year, the company bought the full package of the Onco Card Hospital in Brasov, a purchase that is still subject to analysis by the Competition Council.
Present for 7 years on the Romanian market, through 4 medical centers, Neolife is a member company of the Bozlu group from Turkey, which has 21 companies internationally, working in the field of health and technological services for 32 years. The Neolife brand’s experience in nuclear medicine dates back to 1989 when the first private company to provide such services in a hospital was opened in Turkey. Just one year later, in 1990, the first independent private center was established. Since then, development has been very rapid, and medical diagnostic and cancer treatment services are now provided in more than 60 public and private hospitals in Turkey.
